John O. Agwunobi

John O. Agwunobi (board member) discloses dealings in 3 companies, chiefly Ensign Group, Inc, Herbalife Ltd. and bluebird bio, Inc. We count 34 filings; the first trade dates from 15 June 2021 and the latest from 15 October 2026.

On the open market, the record shows 4 purchases worth €497k and 4 sales worth €204k. Taken together, the purchases exceed the sales by €293k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 24 share grants. Since January 2026: no purchases and 3 sales on the market.

Half of the purchases are above €143k and half below. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +5.5%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 19 October 2026, reports a share grant in Ensign Group, Inc. The last purchase on record was published on 2 May 2024, which is 902 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.